Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Power Life Sciences Inc.
- Study ID
- NCT06101901
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Diabetic Kidney Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The study intends to investigate the personal experiences of diabetic kidney disease patients who take part in a separate clinical study including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal. The data collected from this study will help improve future outcomes for all diabetic kidney disease as well as those in under-represented demographic groups.
Key Dates
- Start date
- Nov 30, 2024
- Status verified
- Oct 2023
- Primary completion
- Nov 30, 2025
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Number of patients who decide to enroll in a diabetic kidney disease clinical research [ Time Frame: 3 months ]
Central Contacts
- Michael B Gill(415) 900-4227
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Power Life Sciences | San Francisco | California | 94107 | - |
Find similar trials in San Francisco, CA
Related Studies
- Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney DiseaseEnrolling By Invitation · University of California, Irvine · Orange, California
- Real World Evidence Clinical Utility Study of KidneyIntelXRecruiting · Renalytix AI, Inc. · New York, New York
- Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)Recruiting · Petter Bjornstad · Aurora, Colorado
- MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 DiabetesPHASE1 · Recruiting · Kalie Tommerdahl · Aurora, Colorado